Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-25

FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application to add an oral solution form of levetiracetam (LEVETIRACETAM SOLUTION) manufactured by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM SOLUTION (LEVETIRACETAM)

Snippet

SUPPL AP for LEVETIRACETAM SOLUTION (LEVETIRACETAM)